此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Lifestyle Intervention to Improve Muscle Function in Older Adults

2026年9月1日 更新者:Candida Rebello、Pennington Biomedical Research Center
The goal of this randomized controlled two-arm trial is to determine the effect of a diet and exercise intervention for 12 weeks on body composition, muscle function, and energy balance in 80 adults aged 50 years and over with obesity and insulin resistance. The main questions the trial aims to answer are: Will 12 weeks of a structured nutrition plan + exercise reduce fat mass, improve muscle function, and increase energy deficit compared to the usual diet + exercise. The hypothesis is that 12 weeks of a structured nutrition plan + exercise will reduce fat mass, improve muscle function, and produce greater energy deficit than the usual diet + exercise. Participants will be provided with all meals for 12 weeks and will exercise at the Center under supervision three times each week. Pre and post-intervention, body composition, physical function, and energy deficit will be measured.

研究概览

详细说明

In the United States nearly one third of adults over 60 years of age have sarcopenic obesity which encompasses the combined effect of muscle impairment and obesity. A strategy that addresses the combined effect of muscle impairment and obesity while modulating muscle mass and composition is an unanswered challenge. This 12-week study will evaluate the effects of a structured nutrition plan combined with an exercise program on body fat and muscle mass, lower-extremity function (Short Physical Performance Battery), muscle strength (handgrip and knee strength), and daily caloric intake. The study will enroll adults aged 50 years and older with obesity (body mass index ≥ 30 kg/m²) and insulin resistance as indicated by a homeostasis model assessment of insulin resistance (HOMA-IR) score ≥ 3. Subjects will be randomly allocated to receive the structured nutrition plan and exercise intervention or to their usual diet and exercise in equal numbers (40 per group). The study will enrich our understanding of the physiological adaptations necessary for effective lifestyle interventions to improve muscle function.

研究类型

介入性

注册 (估计的)

80

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

研究联系人备份

学习地点

    • Louisiana
      • Baton Rouge、Louisiana、美国、70808
        • 招聘中
        • Pennington Biomedical Research Center
        • 接触:
        • 接触:

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

不

描述

Inclusion Criteria:

  1. Age > 50 years.
  2. Body mass index (BMI) ≥ 30 kg/m2.
  3. Homeostatic model assessment of insulin resistance ≥ 3.
  4. Mini-Mental State Examination (MMSE) > 25.
  5. Geriatric Depression Scale-15 (GDS-15) < 9.
  6. Sedentary (less than 90 minutes/week of moderate to vigorous activity).
  7. Ability to provide written informed consent.

Exclusion Criteria:

  1. Diagnosis of cancer (received within five years) or diabetes (type 1 and 2), or significant musculoskeletal, or cardiovascular, or hepatic, or renal, disease or dysfunction.
  2. Clinically significant gastrointestinal malabsorption syndromes such as chronic diarrhea, celiac disease, or clinically significant abnormal laboratory markers.
  3. Fluctuation in body weight > 3 kg in the preceding two months
  4. Condition that impedes testing of the study hypothesis or makes it unsafe to exercise or consume the study foods.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:三倍

武器和干预

参与者组/臂
干预/治疗
实验性的:Structured nutrition plan + exercise
Intervention: Participants receive a structured nutrition plan, and exercise under supervision.
Participants will receive a structured nutrition plan.
Participants will complete aerobic and resistance training under supervision three times per week.
有源比较器:Typical or usual diet + exercise
Participants receive a typical or usual diet, and exercise under supervision
Participants will complete aerobic and resistance training under supervision three times per week.
Participants will receive a diet representing the usual diet in this population.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Fat mass
大体时间:Change from baseline to 12 weeks
Fat mass measured by dual X-ray absorptiometry
Change from baseline to 12 weeks

次要结果测量

结果测量
措施说明
大体时间
Skeletal muscle mass
大体时间:Change in from baseline to 12 weeks
Skeletal muscle mass will be measured by the creatine methyl D-3 dilution method
Change in from baseline to 12 weeks
Short physical performance battery
大体时间:Change from baseline to 12 weeks
A test of physical function
Change from baseline to 12 weeks
Hand-grip strength
大体时间:Change from baseline to 12 weeks
Hand grip strength will be measured using a hand dynamometer
Change from baseline to 12 weeks
Knee strength
大体时间:Change from baseline to12 weeks
Knee strength will be measured quantified using Biodex dynamometry
Change from baseline to12 weeks
Energy stores
大体时间:12 weeks
Change in energy stores/day (kcal) determined from measures of body composition using the energy balance method
12 weeks
Hormonal regulation of energy balance
大体时间:Change from baseline to 12 weeks
Blood concentrations of glucagon-like peptide 1
Change from baseline to 12 weeks
Hormonal regulation of energy balance
大体时间:Change from baseline to 12 weeks
Blood concentrations of gastric inhibitory peptide
Change from baseline to 12 weeks
Hormonal regulation of energy balance
大体时间:Change from baseline to 12 weeks
Blood concentrations of cortisol
Change from baseline to 12 weeks
Hormonal regulation of energy balance
大体时间:Change from baseline to 12 weeks
Blood concentrations of leptin
Change from baseline to 12 weeks
Cardiorespiratory fitness
大体时间:Change in VO2max from baseline to 12 weeks
VO2max
Change in VO2max from baseline to 12 weeks

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Candida J Rebello, PhD, RD、Pennington Biomedical Research Center

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2026年7月20日

初级完成 (估计的)

2030年12月1日

研究完成 (估计的)

2030年12月1日

研究注册日期

首次提交

2026年5月8日

首先提交符合 QC 标准的

2026年5月14日

首次发布 (实际的)

2026年5月20日

研究记录更新

最后更新发布 (实际的)

2026年9月3日

上次提交的符合 QC 标准的更新

2026年9月1日

最后验证

2026年7月1日

更多信息

与本研究相关的术语

其他研究编号

  • PBRC-2025-060
  • 1R01AG092725-01A1 (美国 NIH 拨款/合同)

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

IPD 计划说明

At this time, we do not have plans to share IPD. We may consider it after the study results have been publicly disseminated

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅